Skip to main content
. 2018 Jan 18;41(4):1855–1866. doi: 10.3892/ijmm.2018.3405

Figure 1.

Figure 1

Differential expression of miR-21-5p in GC patients. (A) Relative expression of miR-21-5p (normalized to U6) in GC and matched adjacent NC tissues was measured by reverse transcription quantitative-polymerase chain reaction analysis. (B) Primary GC samples (n=30) were divided according to clinical outcomes. Patients who developed distant recurrence or succumbed had significantly higher miR-21-5p expression than those who had CR after treatment. CR, complete remission; miR, microRNA; NC, normal control; GC, gastric cancer.